Urinalysis Market Worth $2.14 Billion by 2022 | Key Players include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex
The global urinalysis market size was estimated at USD 1.37 billion in 2015.The magnitude of the target diseases, such as UTI, kidney diseases, and diabetes, is immense with the occurrence of millions of new cases every year.
(firmenpresse) - Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.
Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray), and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.
The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.
The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.
Further key findings from the study suggest:
recast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
healthcare spending in this region are the key factors attributing to the largest market share of this region.
ith an objective to enhance staff safety and increase the result reliability.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com
Datum: 23.03.2020 - 13:23 Uhr
Sprache: Deutsch
News-ID 1557005
Anzahl Zeichen: 3813
contact information:
Contact person:
Town:
San Francisco
Phone: 1-888-202-9519
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 23.03.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 1759 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Urinalysis Market Worth $2.14 Billion by 2022 | Key Players include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
